TG Therapeutics: Q4 Earnings Snapshot

MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Wednesday reported a loss of $14.4 million in its fourth quarter.

On a per-share basis, the Morrisville, New York-based company said it had a loss of 9 cents.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.

The biopharmaceutical company posted revenue of $44 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $40.1 million.

For the year, the company reported profit of $12.7 million, or 9 cents per share. Revenue was reported as $233.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX